Ascend Wellness Holdings (AAWH) Non-Current Assets (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Non-Current Assets of $683.1 million for Q1 2026, up 0.56% year-over-year from $679.4 million in Q1 2025, and down 2.27% quarter-over-quarter from $699.0 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Non-Current Assets (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Non-Current Assets history runs 7 years deep, the most recent figure standing at $683.1 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 0.56% year-over-year to $683.1 million; the TTM figure through Mar 2026 stood at $1.9 billion (down 32.07% YoY), while the FY2025 annual figure was $699.0 million, up 4.16% from the prior year.
- Non-Current Assets for Q1 2026 stood at $683.1 million, down from $699.0 million in the prior quarter.
- The five-year high for Non-Current Assets was $699.0 million in Q4 2025, with the low at -$208.8 million in Q3 2025.
- The 5-year median for Non-Current Assets is $679.4 million (2025), against an average of $607.7 million.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets jumped 189.73% in 2022, then tumbled 130.6% in 2025.
- Ascend Wellness Holdings' Non-Current Assets stood at $673.4 million in 2022, then rose by 2.56% to $690.7 million in 2023, then decreased by 2.84% to $671.1 million in 2024, then grew by 4.16% to $699.0 million in 2025, then decreased by 2.27% to $683.1 million in 2026.
- Business Quant data shows AAWH's Non-Current Assets at $683.1 million in Q1 2026, $699.0 million in Q4 2025, and -$208.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 2.96 Bn |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | 701.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 701.46 Mn |
| Mar 31, 2026 | 683.13 Mn |
| Dec 31, 2025 | 698.98 Mn |
| Sep 30, 2025 | -208.81 Mn |
| Jun 30, 2025 | 678.21 Mn |
| Mar 31, 2025 | 679.36 Mn |
| Dec 31, 2024 | 671.06 Mn |
| Sep 30, 2024 | 682.30 Mn |
| Jun 30, 2024 | 693.10 Mn |
| Mar 31, 2024 | 689.82 Mn |
| Dec 31, 2023 | 690.69 Mn |
| Sep 30, 2023 | 696.66 Mn |
| Jun 30, 2023 | 686.42 Mn |
| Mar 31, 2023 | 665.88 Mn |
| Dec 31, 2022 | 673.42 Mn |
| Sep 30, 2022 | 628.12 Mn |
| Jun 30, 2022 | 568.84 Mn |
| Mar 31, 2022 | 453.65 Mn |
| Dec 31, 2021 | 465.42 Mn |
| Sep 30, 2021 | 417.22 Mn |